Ohio Public Employees Retirement System (OPERS)’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-99,000	Closed	-$4.75M	–	1975
2020 Q1	$4.75M	Buy	99,000 +69,000	+230%	+$3.21M	0.03%	470
2019 Q4	$1.41M	Buy	+30,000	New	+$1.33M	0.01%	1059

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s RARX Position: Q2 2020 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 99,000 shares — an estimated $4.75M sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $4.75M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Ohio Public Employees Retirement System (OPERS) reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 99,000 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $4.75M.
Ohio Public Employees Retirement System (OPERS) first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Ohio Public Employees Retirement System (OPERS)'s Ra Pharmaceuticals, Inc. Common Stock position peaked at $4.75M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2020, filed 17 Aug 2020.